COVID-19 treatment, Keytruda boost Merck in 1Q
Better-than-expected sales of a COVID-19 treatment and its cancer blockbuster Keytruda helped push Merck past analyst ...
Read moreBetter-than-expected sales of a COVID-19 treatment and its cancer blockbuster Keytruda helped push Merck past analyst ...
Read moreMerck & Co Inc said on Wednesday the US government has agreed to purchase about 1.7 ...
Read moreSYDNEY (World) - An experimental drug developed by an Australian researcher could help prevent deaths from ...
Read moreSINGAPORE (Business) - Singapore's Tychan, a biotechnology firm backed by state investor Temasek Holdings, said it ...
Read moreNEW YORK (Business) - Investors are diversifying bets in the healthcare sector, as the rush to ...
Read more